Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Cancer Treatment and Research
|
January 1, 1996
Antifolates: current developments
E A Rayl, G Pizzorno
The Cancer Journal From Scientific American
|
March 1, 1997
The use of chemotherapy resistance in cancer treatment
A B Deisseroth, G Pizzorno
Biochemical Pharmacology
|
February 14, 1995
Effect of clinically modeled regimens on the growth response and development of resistance in human colon carcinoma cell lines
G Pizzorno, R E Handschumacher
Biochemical Pharmacology
|
February 14, 1995
Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil
G Pizzorno, Z Sun, R E Handschumacher
Cancer Research
|
September 18, 2001
p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction
D Zhang, D Cao, R Russell, et al.
Biochemical Pharmacology
|
June 1, 1994
Enhancement of antineoplastic activity of 5-fluorouracil in mice bearing colon 38 tumor by (6R)5,10-dideazatetrahydrofolic acid
G Pizzorno, S J Davis, D J Hartigan, et al.
Cancer Research
|
December 16, 1998
Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors
M Liu, D Cao, R Russell, et al.
Current Medical Research and Opinion
|
January 1, 1986
Ketotifen treatment of adverse reactions to foods: clinical and immunological effects
G Ciprandi, A Scordamaglia, S Ruffoni, et al.
Cancer Research
|
May 1, 1991
(6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells
G Pizzorno, B A Moroson, A R Cashmore, et al.
Cancer Research
|
April 1, 1992
Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools
G Pizzorno, R A Wiegand, S K Lentz, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Cancer Treatment and Research
|
January 1, 1996
Antifolates: current developments
E A Rayl, G Pizzorno
The Cancer Journal From Scientific American
|
March 1, 1997
The use of chemotherapy resistance in cancer treatment
A B Deisseroth, G Pizzorno
Biochemical Pharmacology
|
February 14, 1995
Effect of clinically modeled regimens on the growth response and development of resistance in human colon carcinoma cell lines
G Pizzorno, R E Handschumacher
Biochemical Pharmacology
|
February 14, 1995
Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil
G Pizzorno, Z Sun, R E Handschumacher
Cancer Research
|
September 18, 2001
p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction
D Zhang, D Cao, R Russell, et al.
Biochemical Pharmacology
|
June 1, 1994
Enhancement of antineoplastic activity of 5-fluorouracil in mice bearing colon 38 tumor by (6R)5,10-dideazatetrahydrofolic acid
G Pizzorno, S J Davis, D J Hartigan, et al.
Cancer Research
|
December 16, 1998
Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors
M Liu, D Cao, R Russell, et al.
Current Medical Research and Opinion
|
January 1, 1986
Ketotifen treatment of adverse reactions to foods: clinical and immunological effects
G Ciprandi, A Scordamaglia, S Ruffoni, et al.
Cancer Research
|
May 1, 1991
(6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells
G Pizzorno, B A Moroson, A R Cashmore, et al.
Cancer Research
|
April 1, 1992
Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools
G Pizzorno, R A Wiegand, S K Lentz, et al.
Page
of 5